New data and analyses presented at the American Diabetes Association’s annual meeting highlight the priorities for the next ...

Eli Lilly reported impressive data at the recent American Diabetes Association ('ADA') conference. Its robust pipeline will ...

The weight-loss drug boom has dominated headlines for the last two years — but underneath the hype lies a major flaw in the ...

Nicotinic receptors — a family of ligand-gated ion channels that mediate the effects of the neurotransmitter acetylcholine — are among the most well understood allosteric membrane proteins ...

Blockade of the A2A adenosine receptor (A2AAR) by small-molecule antagonists holds promise for enhancing the efficacy of immune checkpoint inhibitors such as PD-L1 antibodies. However, many A2AAR ...

The sarcopenia market size shall grow during the forecast period (2025–2034) due to the launch of upcoming therapies and the increasing cases ...

What new targets will iBio announce during the call? iBio will announce a third target in the AstralBio Collaboration, alongside Myostatin and Activin E. Where can I find the webcast of the call?

GPCRs (G-protein [guanine nucleotide-binding protein]–coupled receptors) play a central physiological role in the regulation of cardiac function in both health and disease and thus represent one of ...

Research suggests that the peptide may function as a competitive antagonist to myostatin, thereby impacting muscle cell proliferation. Research indicates that Follistatin-344 may interact with activin ...

Receptor–ligand interactions on cell membrane play key roles in many physiological and pathological processes, especially in the nanodrug targeted delivery system. Hyaluronic acid (HA) is the main ...